Loading...
XASEYCBD
Market cap1mUSD
Dec 23, Last price  
0.34USD
1D
-4.94%
1Q
-29.41%
IPO
-93.67%
Name

Level Brands Inc

Chart & Performance

D1W1MN
XASE:YCBD chart
P/E
—
P/S
0.05
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
61.09%
Rev. gr., 5y
-3.80%
Revenues
19m
-19.35%
2,031,5624,474,9538,420,14223,651,55141,883,73444,480,76335,403,22424,155,36219,482,167
Net income
-4m
L-83.87%
-3,356,489-1,738,734-412,075-45,429,77612,602,273-23,394,889-74,085,698-22,938,209-3,700,126
CFO
-353k
L-91.80%
-2,897,254-2,329,841-5,573,095-15,377,467-10,664,336-14,093,433-14,967,150-4,302,051-352,792
Earnings
Feb 11, 2025

Profile

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.
URL
https://www.cbdmd.com/
IPO date
Nov 17, 2017
Employees
90
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
19,482
-19.35%
24,155
-31.77%
35,403
-20.41%
Cost of revenue
20,149
25,924
44,950
Unusual Expense (Income)
NOPBT
(667)
(1,768)
(9,547)
NOPBT Margin
Operating Taxes
4,002
Tax Rate
NOPAT
(667)
(1,768)
(13,549)
Net income
(3,700)
-83.87%
(22,938)
-69.04%
(74,086)
216.67%
Dividends
(3,668)
(4,002)
Dividend yield
175.27%
1,338.98%
Proceeds from repurchase of equity
50
2,478
BB yield
-2.47%
-118.40%
Debt
Debt current
1,270,103
1,280
1,188
Long-term debt
99
6,084
8,539
Deferred revenue
Other long-term liabilities
90
401
Net debt
1,267,049
4,865
607
Cash flow
Cash from operating activities
(353)
(4,302)
(14,967)
CAPEX
(190,015)
(298)
(689)
Cash from investing activities
(290)
702
(689)
Cash from financing activities
1,298
(1,323)
(4,035)
FCF
7,347,227
1,023
(11,231)
Balance
Cash
2,453
1,798
7,720
Long term investments
700
700
1,400
Excess cash
2,178
1,290
7,350
Stockholders' equity
(182,058,959)
(174,356)
(147,358)
Invested Capital
174,721,603
187,160
184,052
ROIC
ROCE
0.01%
EV
Common stock shares outstanding
4,313
2,022
1,328
Price
0.47
-54.59%
1.04
359.80%
0.23
-89.18%
Market cap
2,027
-3.16%
2,093
600.31%
299
-88.23%
EV
1,274,076
6,963
911
EBITDA
1,154
1,159
(6,576)
EV/EBITDA
1,104.38
6.01
Interest
16
Interest/NOPBT